Yifan Pharmaceutical Balance Sheet Health
Financial Health criteria checks 3/6
Yifan Pharmaceutical has a total shareholder equity of CN¥8.4B and total debt of CN¥2.1B, which brings its debt-to-equity ratio to 25.4%. Its total assets and total liabilities are CN¥12.1B and CN¥3.7B respectively. Yifan Pharmaceutical's EBIT is CN¥147.8M making its interest coverage ratio 2.5. It has cash and short-term investments of CN¥867.6M.
Key information
25.4%
Debt to equity ratio
CN¥2.14b
Debt
| Interest coverage ratio | 2.5x |
| Cash | CN¥867.60m |
| Equity | CN¥8.44b |
| Total liabilities | CN¥3.69b |
| Total assets | CN¥12.14b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 002019's short term assets (CN¥3.9B) exceed its short term liabilities (CN¥2.8B).
Long Term Liabilities: 002019's short term assets (CN¥3.9B) exceed its long term liabilities (CN¥906.3M).
Debt to Equity History and Analysis
Debt Level: 002019's net debt to equity ratio (15.1%) is considered satisfactory.
Reducing Debt: 002019's debt to equity ratio has increased from 24.3% to 25.4% over the past 5 years.
Debt Coverage: 002019's debt is not well covered by operating cash flow (15.8%).
Interest Coverage: 002019's interest payments on its debt are not well covered by EBIT (2.5x coverage).